Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...

Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial.

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.